This type of technology is a world first : entirely bioresorbable and printed in 3D, the implant makes it possible to regenerate the autologous adipose tissue in a natural way and with a single surgery which is completely resorbed from the body following reconstruction of the breast.
L’entry into clinical phase with around fifty patients in Georgia, France and Spain, confirms the work undertaken over the past three years by Lattice Medical (Eurasanté) which validated all the necessary prerequisites and published these results in three scientific journals, confirming to the both the performance of the device and its safety.
The company, founded by Julien Payen, currently has around twenty employees and a 3D printing production site in Lille.
